Ventricular Assisted Devices Market to Reach $4.1 Billion, Globally, by 2035 at 8.1% CAGR: Allied Market Research [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
PORTLAND, Ore. May 14, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, "Ventricular Assist Devices Market By Product (Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), and Biventricular Assist Devices (BIVADs)), Application (Bridge-To-Transplant (BTT), Destination Therapy, Bridge-To-Recovery (BTR), and Bridge To Candidacy Therapy), Design (Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices), and Age (Adults and Pediatrics): Global Opportunity Analysis And Industry Forecast, 2024-2035". According to the report, the global ventricular assisted devices market was valued at .6 billion in 2023 and is estimated to reach $4.1 billion by 2035 , exhibiting a CAGR of 8.1% from 2023 to 2035. Request Sample of the Report on Ventricular Assisted Devices Market Forecast 2035- https://www.alliedmarketresearch.com/request-sample/2024 Prime determinants of growth Rise in adoption of ventricular assisted d
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Wins FDA Approval For Two Over-The-Counter Diabetes Trackers [Forbes]Forbes
- Companion Diagnostics Market Anticipated To Grow At 12.5% CAGR, Reaching USD 26.0 Billion By 2033 | Dimension Market Research [Yahoo! Finance]Yahoo! Finance
- Irish Tax Appeals Court Botches First Transfer Pricing Decision [Forbes]Forbes
- Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems [Yahoo! Finance]Yahoo! Finance
- Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring SystemsPR Newswire
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 5/30/24 - Form SD
- 5/14/24 - Form 4
- 5/10/24 - Form 144
- ABT's page on the SEC website